Revance Therapeutics Inc
Top 10 Superinvestors by Shares Owned
This chart shows the top 10 superinvestors based on the number of shares they owned in 2024-Q2 and 2024-Q3. According to the most recent SEC 13F filing, 24 superinvestors own shares of Revance Therapeutics Inc (761330AB5), although recent data may remain incomplete due to pending filings.
Quarter-over-Quarter Change (%)
This chart highlights the quarter-over-quarter change (%) in the number of superinvestors holding Revance Therapeutics Inc (761330AB5), the total shares they held, and the total reported dollar value. It gives a clear view of whether there is ongoing momentum. The dotted lines at the top and bottom adjust longer bars to keep smaller data points visible for better comparison.
Superinvestors' Activity (%) Over the Last 4 Quarters
This chart shows superinvestors' activity with Revance Therapeutics Inc (761330AB5) over the last four quarters, highlighting the percentage of investors who added, increased, decreased, held, or exited their positions, revealing shifts in sentiment over time.
Superinvestors' Past Actions
This chart displays superinvestors' past actions with Revance Therapeutics Inc (761330AB5) over the last 10 years (40 quarters), helping to visualize the collective momentum and investment trends over time.
Superinvestors ownership
| Superinvestor | Portfolio % | Reported Value | Recent Activity |
|---|---|---|---|
Daniel R. Marcus@D. E. Shaw & Co., Inc.
| 0.02% | $14.706M 17.23M shares@ 0.86 avg price | Decreased -57.58% |
Debora L. Burrowes@Morgan Stanley
| 0.01% | $2.472M 2.924M shares@ 0.85 avg price | Decreased -39.77% |
Sara S. Alexander@Sonora Investment Management Group, Llc
| 0.19% | $2.526M 2.905M shares@ 0.87 avg price | Decreased -4.28% |
Otis H. Cowan@American Century Companies Inc
| 0.01% | $90,662 106,000 shares@ 0.86 avg price | Decreased -9.4% |
Grace Brescia@Context Capital Management, Llc
| 1.23% | $44.903M 52,500 shares@ 855.3 avg price | Decreased -4.96% |